COVID-19. COVID-19, virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Ages between 18-60 years Inpatients of the wards Daily Lopinavir / Ritonavir PCR confirmed COVID-19 Without background disease
Exclusion criteria
Exclusion criteria: Age above 60 and below 18 Cardiovascular disease Diabetes Autoimmune disease Renal disease Respiratory distress on admission time Allergy history Consumption of cardiovascular drugs, anti diabetes, anti coagulants, anti HIV, anti cholesterol, immunsuppressive, and cancer chemotherapy agents Reluctance to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| O2 saturation. Timepoint: Measurement of oxygen saturation every day during the study. Method of measurement: Pulse oximetry device.;Adverse drug reaction. Timepoint: Daily recording of possible adverse effects of the extract. Method of measurement: Observational recording. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences